Braskem S.A.

DB:BRDA Stock Report

Market Cap: €1.6b

Braskem Valuation

Is BRDA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BRDA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
€4.69
Fair Value
60.4% undervalued intrinsic discount
12
Number of Analysts

Below Fair Value: BRDA (€1.86) is trading below our estimate of fair value (€4.69)

Significantly Below Fair Value: BRDA is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for BRDA?

Key metric: As BRDA is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for BRDA. This is calculated by dividing BRDA's market cap by their current revenue.
What is BRDA's PS Ratio?
PS Ratio0.1x
SalesR$74.95b
Market CapR$10.11b

Price to Sales Ratio vs Peers

How does BRDA's PS Ratio compare to its peers?

The above table shows the PS ratio for BRDA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.7x
FPE3 Fuchs
1.5x3.5%€4.7b
SIM0 SIMONA
0.6xn/a€333.0m
LXS LANXESS
0.3x2.5%€2.1b
SDF K+S
0.6x0.6%€2.0b
BRDA Braskem
0.1x7.0%€10.1b

Price-To-Sales vs Peers: BRDA is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (0.7x).

Price to Sales Ratio vs Industry

How does BRDA's PS Ratio compare vs other companies in the European Chemicals Industry?

28 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.1.1x4.2%
BRDA Braskem
 0.1x7.0%US$1.66b
BRDA 0.1xIndustry Avg. 1.1xNo. of Companies28PS01.22.43.64.86+
28 CompaniesEstimated GrowthMarket Cap
Industry Avg.1.1x33.9%
BRDA Braskem
 0.1x115.7%US$1.66b
No more companies

Price-To-Sales vs Industry: BRDA is good value based on its Price-To-Sales Ratio (0.1x) compared to the European Chemicals industry average (1.1x).

Price to Sales Ratio vs Fair Ratio

What is BRDA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BRDA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.1x
Fair PS Ratio0.4x

Price-To-Sales vs Fair Ratio: BRDA is good value based on its Price-To-Sales Ratio (0.1x) compared to the estimated Fair Price-To-Sales Ratio (0.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst BRDA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€1.86
€3.70
+98.9%
15.6%€4.47€2.56n/a12
Jan ’26€1.80
€3.83
+112.9%
19.4%€5.51€2.84n/a12
Dec ’25€2.06
€4.14
+100.8%
18.0%€5.54€2.85n/a13
Nov ’25€2.70
€4.29
+59.1%
15.5%€5.59€3.20n/a13
Oct ’25€3.06
€4.47
+46.1%
15.1%€5.77€3.30n/a13
Sep ’25€2.58
€4.44
+72.2%
15.5%€5.73€3.28n/a12
Aug ’25€2.64
€4.48
+69.8%
15.7%€5.70€3.26n/a12
Jul ’25€3.10
€4.74
+53.1%
17.2%€6.12€3.50n/a12
Jun ’25€3.60
€5.00
+39.0%
15.5%€6.28€3.59n/a12
May ’25€4.02
€5.25
+30.7%
18.3%€7.22€3.61n/a12
Apr ’25€4.92
€5.39
+9.5%
19.8%€7.42€4.08n/a10
Mar ’25€4.18
€5.41
+29.4%
21.7%€7.49€4.12n/a10
Feb ’25€3.40
€5.50
+61.6%
22.5%€7.54€4.15n/a9
Jan ’25€4.00
€5.50
+37.4%
22.5%€7.54€4.15€1.809
Dec ’24€3.34
€5.77
+72.7%
27.0%€8.92€4.09€2.0610
Nov ’24€2.94
€5.82
+98.0%
26.9%€8.96€3.73€2.7010
Oct ’24€3.72
€7.06
+89.7%
40.9%€14.99€3.84€3.0611
Sep ’24€4.02
€7.07
+75.9%
38.9%€14.66€3.76€2.5811
Aug ’24€4.68
€7.41
+58.4%
35.2%€14.81€4.94€2.6411
Jul ’24€5.25
€7.50
+42.8%
34.8%€14.93€4.98€3.1011
Jun ’24€4.06
€6.83
+68.1%
38.4%€14.42€4.07€3.6012
May ’24€3.50
€6.70
+91.5%
41.6%€14.04€3.96€4.0213
Apr ’24€3.44
€6.97
+102.5%
40.5%€14.03€3.96€4.9213
Mar ’24€3.66
€8.85
+141.9%
33.2%€14.08€4.69€4.1812
Feb ’24€4.36
€8.90
+104.0%
32.1%€14.05€4.86€3.4012
Jan ’24€4.20
€9.18
+118.6%
27.3%€13.82€5.31€4.0012
Analyst Price Target
Consensus Narrative from 12 Analysts
€3.40
Fair Value
45.3% undervalued intrinsic discount
12
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/20 14:56
End of Day Share Price 2025/01/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Braskem S.A. is covered by 30 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Luiz Otávio Broad Acatauassu NunesAgora Senior
null nullAlembic Global Advisors
Daniel CobucciBB Banco de Investimento S.A.